tiprankstipranks
SURTECO SE (GB:0HHI)
LSE:0HHI

SURTECO (0HHI) Income Statement

0 Followers

SURTECO Income Statement

Last quarter (Q4 2022), SURTECO's total revenue was €154.74M, a decrease of -18.95% from the same quarter last year. In Q4, SURTECO's net income was €-2.18M. See SURTECO’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
€ 747.70M€ 747.70M€ 757.06M€ 626.99M€ 675.27M€ 698.98M
Cost of Revenue
€ 387.16M€ 387.16M€ 365.63M€ 287.70M€ 325.01M€ 342.11M
Gross Profit
€ 360.53M€ 360.53M€ 391.43M€ 339.29M€ 350.26M€ 356.86M
Operating Expense
€ 326.97M€ 326.97M€ 320.27M€ 293.99M€ 330.55M€ 324.41M
Operating Income
€ 33.56M€ 33.56M€ 71.16M€ 45.29M€ 19.71M€ 32.46M
Net Non Operating Interest Income Expense
€ -4.01M€ -4.01M€ -4.37M€ -4.46M€ -7.06M€ -6.06M
Other Income Expense
------
Pretax Income
€ 36.82M€ 36.82M€ 69.97M€ 43.30M€ 16.22M€ 27.13M
Tax Provision
€ 11.59M€ 11.59M€ 22.16M€ 9.53M€ 6.46M€ 8.20M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
€ 25.23M€ 25.23M€ 47.81M€ 33.69M€ 9.43M€ 18.63M
Basic EPS
€ 1.31€ 1.63-€ 2.17€ 0.61€ 1.20
Diluted EPS
€ 1.31€ 1.63-€ 2.17€ 0.61€ 1.20
Basic Average Shares
€ 46.52M€ 15.51M-€ 15.51M€ 15.51M€ 15.51M
Diluted Average Shares
€ 46.52M€ 15.51M-€ 15.51M€ 15.51M€ 15.51M
Dividend Per Share
€ 1.00€ 1.00-€ 0.00€ 0.55€ 0.80
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
€ 714.14M€ 714.14M€ 685.90M€ 581.70M€ 655.56M€ 666.52M
Net Income From Continuing And Discontinued Operation
€ 25.23M€ 25.23M€ 47.81M€ 33.69M€ 9.43M€ 18.63M
Normalized Income
€ 25.23M€ 21.27M€ 47.19M€ 31.61M€ 9.25M€ 19.74M
Interest Expense
-€ 5.00M€ 4.81M€ 4.76M€ 7.34M€ 7.49M
EBIT
€ 41.82M€ 41.82M€ 74.78M€ 48.05M€ 23.56M€ 34.62M
EBITDA
€ 85.82M€ 85.82M€ 117.02M€ 90.23M€ 68.74M€ 75.20M
Currency in EUR

SURTECO Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis